A Study of Apalutamide (ARN-509) in Men With Non-Metastatic Castration-Resistant Prostate Cancer

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

1,207

Participants

Timeline

Start Date

October 14, 2013

Primary Completion Date

May 19, 2017

Study Completion Date

December 31, 2027

Conditions
Prostatic Neoplasms
Interventions
DRUG

Apalutamide

240 mg tablets administered by mouth on a continuous once daily dosing regimen

DRUG

Placebo

Matched placebo tablets administered by mouth on a continuous once daily dosing regimen

Trial Locations (379)

Unknown

Birmingham

Anchorage

Chandler

Tucson

Duarte

Fullerton

Laguna Woods

Los Angeles

Orange

Roseville

Sacramento

San Bernardino

San Diego

San Francisco

Santa Monica

Sherman Oaks

Stanford

Tarzana

Torrance

Denver

Englewood

Glenwood Springs

Grand Junction

Washington D.C.

Aventura

Boca Raton

Bradenton

Daytona Beach

Fort Myers

Hialeah

Jacksonville

Miami

New Port Richey

Orlando

Sarasota

St. Petersburg

Wellington

Meridian

Chicago

Decatur

Maywood

Melrose Park

Carmel

Jeffersonville

Muncie

West Des Moines

Westwood

Wichita

Metairie

New Orleans

Annapolis

Baltimore

Rockville

Towson

Boston

Detroit

Lansing

Minneapolis

Royal Oak

Duluth

Bay Saint Louis

Southaven

Kansas City

Missoula

Omaha

Las Vegas

Hooksett

Hackensack

Lawrenceville

Morristown

Mount Laurel

New Brunswick

Voorhees Township

Albuquerque

Albany

Mineola

New York

Oneida

Poughkeepsie

Syracuse

The Bronx

Concord

Greensboro

Greenville

Salisbury

Winston-Salem

Cincinnati

Cleveland

Middleburg Heights

Middletown

Bend

Portland

Tualatin

Bala-Cynwyd

Bryn Mawr

Lancaster

Philadelphia

Pittsburgh

Warwick

Charleston

Greenville

Myrtle Beach

West Columbia

Memphis

Nashville

Abilene

Amarillo

Dallas

Fort Sam Houston

Houston

McAllen

San Antonio

Norfolk

Richmond

Virginia Beach

Burien

Edmonds

Seattle

Tacoma

Green Bay

Madison

Milwaukee

Adelaide

Box Hill

Camperdown

Darlinghurst

Geelong

Gosford

Hobart

Kogarah

Liverpool

Melbourne

Nedlands

Parkville

South Woodville

Southport

Sydney

Tweed Heads

Wollongong

Graz

Innsbruck

Linz

Vienna

Brussels

Ghent

Kortrijk

Leuven

Liège

Ottignies

Calgary

Edmonton

Abbotsford

Kelowna

Vancouver

Victoria

Moncton

Saint John

Halifax

Barrie

Brampton

Brantford

Hamilton

London

North York

Oakville

Ottawa

Owen Sound

Toronto

Gatineau

Granby

Greenfield Park

Laval

Montreal

Pointe-Claire

Québec

Sherbrooke

Liberec

Olomouc

Opava

Pilsen

Prague

Aalborg C

Copenhagen

Odense

Roskilde

Helsinki

Oulu

Seinäjoki

Tampere

Turku

Angers

Besançon

Bordeaux

Caen Cédex 05

Clermont-Ferrand

Hyers

La Roche-sur-Yon

Le Mans

Lille Cedex N/a

Lyon

Marseille

Nice

Nîmes

Paris

Reims

Rennes

Rouen

Saint-Grégoire

Saint-Herblain

Strasbourg

Suresnes

Tours

Vandœuvre-lès-Nancy

Aachen

Bergisch Gladbach

Berlin

Braunschweig

Cologne

Duisburg

Emmendingen

Frankfurt am Main

Göttingen

Greifswald

Hamburg

Hanover

Heidelberg

Heinsberg

Homburg/Saar

Jena

Kiel

Kirchheim unter Teck

Magdeburg

Mainz

Mannheim

Marburg

Mettmann

Müllheim

Münster

Nürtingen

Regensburg

Rostock

Tübingen

Weiden

Wilhelmshaven

Wuppertan

Zirndorf

Budapest

Miskolc

Nyíregyhá

Sopron

Szentes

Haifa

Jeruselem

Kfar Saba

Petah Tikva

Ramat Gan

Tel Aviv

Ẕerifin

Akita

Fukuoka

Gifu

Hakodate

Hiroshima

Hokkaido

Kanazawa

Kashiwa

Kita-Gun

Kobe

Koshigaya

Kumamoto

Kurume

Matsuyama

Nagano

Nagasaki

Nagoya

Niigata

Osaka

Ōsaka-sayama

Sagamihara

Sakura

Sapporo

Shinjuku-Ku

Tokushima

Tokyo

Ube

Wakayama

Yokohama

Alkmaar

Eindhoven

Hoofddorp

Leidschendam

Nijmegen

Rotterdam

Auckland

Christchurch

Hamilton

Nelson

Tauranga

Whangarei

Nordbyhagen

Bialystok

Bydgoszcz

Gdansk

Kutno

Lodz

Poznan

Szczecin

Torun

Warsaw

Wroclaw

Baia Mare

Brasov

Bucharest

Cluj-Napoca

Târgu Mureş

Barnaul

Ivanovo

Moscow

Obninsk

Omsk

Ryazan

Saint Petersburg

Ufa

Yaroslavl

Yekaterinburg

Banská Bystrica

Bratislava

Martin

Nitra

Trenčín

Daegu

Gwangju

Pusan

Seongnam

Seoul

A Coruña

Badalona

Barcelona

Castellon

Girona

Guadalajara

Jerez de la Frontera

Las Palmas de Gran Canaria

Madrid

Málaga

Murcia

Palma de Mallorca

Pamplona

Sabadell

Salamanca

San Sebastián de los Reyes

Santander

Seville

Valencia

Gothenburg

Örebro

Stockholm

Umeå

Uppsala

Kaohsiung City

Taichung

Taipei

Taoyuan

Blackburn

Cambridge

Cardiff

Dundee

Glasgow

Guildford

Leeds

London

Maidstone

Metropolitan Borough of Wirral

Nottingham

Plymouth

Southampton

Surrey

Swansea

Wolverhampton

Sponsors
All Listed Sponsors
lead

Aragon Pharmaceuticals, Inc.

INDUSTRY

NCT01946204 - A Study of Apalutamide (ARN-509) in Men With Non-Metastatic Castration-Resistant Prostate Cancer | Biotech Hunter | Biotech Hunter